Japan's Daiichi Sankyo launches up to $3.6 billion stake sale in India's Sun Pharma

April 20, 2015 12:07 PM

56 0

Japan's Daiichi Sankyo launches up to $3.6 billion stake sale in India's Sun Pharma

MUMBAI (Reuters) - Japan's Daiichi Sankyo Company Ltd (4568.T) is selling its stake worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd (SUN.NS), a person directly involved in the deal said on Monday.

The Japanese company is selling its 8.9 percent stake in Sun Pharma, India's largest drugmaker by sales, via block deals on the Indian exchanges, said the person, who declined to be named as he was not authorized to speak to the media.

Also read: Microsoft Closes Acquisition of LinkedIn

Read more

To category page

Loading...